Pyrido-pyrimidinone Derivatives as RIPK2 Kinase and NOD Signaling Inhibitors

Simple item page
dc.contributor.advisorCuny, Gregory D.
dc.contributor.committeeMemberDas, Joydip
dc.contributor.committeeMemberRuan, Ke-He
dc.contributor.committeeMemberDegterev, Alexei
dc.contributor.committeeMemberMay, Jeremy A.
dc.creatorNikhar, Sameershivnath
dc.creator.orcid0000-0002-0542-4545
dc.date.accessioned2019-05-23T15:23:12Z
dc.date.createdAugust 2018
dc.date.issued2018-08
dc.date.submittedAugust 2018
dc.date.updated2019-05-23T15:23:12Z
dc.description.abstractReceptor interacting protein kinase-2 (RIPK2) is an enzyme that transduces pro-inflammatory signaling from the nucleotide binding oligomerization containing proteins (NOD1/2) during bacterial invasion in immune cells. However, NOD 1/2 mutations cause uncontrolled activation of RIPK2, resulted in excessive signaling and cytokine production. Such dysregulated signaling has been associated with inflammatory bowel (Crohn’s disease) and neuro-inflammatory diseases (Multiple Sclerosis), making RIPK2 an important target. Although, several RIPK2 kinase inhibitors have been reported in the literature, they possess limitations including off-target effects, reduced cellular potency, compromised in vivo efficacy and hERG/CYP inhibition. Thus, novel types of RIPK2 inhibitors are needed to address such problems. To this end we have identified a pyrido-pyrimidine based inhibitor (UH15) that has shown potent RIPK2 inhibition in enzymes and cells, but also showed non-selective inhibition of structurally similar activin like kinase-2 (ALK2). Nevertheless, molecular docking studies of UH15 in RIPK2 and ALK2 identified key differences that have been used to optimize the compound towards potent and selective RIPK2 inhibitors. The docking model-based optimization of UH15 identified two sets of analogs that differentiate RIPK2 inhibition in cells based upon size and position of substituents at a specific site on the inhibitor. Compounds that occupy the shallow hydrophobic pocket between the β3/β5 strands and the α-C helix in the kinase domain, showed effective RIPK2 cellular inhibition. The behavior of this subset of UH15 inhibitors correlates to the recently identified CSLP compounds that have shown RIPK2 cellular potency by interfering with RIPK2-XIAP interaction after occupying the hydrophobic pocket. The most potent and selective RIPK2 inhibitor (UH15-15) has shown optimal absorption, distribution, metabolism and excretion (ADME) and pharmacokinetic (PK) properties, making it a suitable probe for delineating the role of RIPK2 in disease models. Furthermore, modifications of the central pyrido-pyrimidine scaffold of UH15 series resulted in several other distinct structural classes of RIPK2 inhibitors. Overall, the identified RIPK2 inhibitors show mechanism based cellular potency, selectivity verses the structurally similar ALK2 kinase and promising pharmacokinetic properties. These compounds will allow investigation of RIPK2 function in disease models and will provide the basis for further optimization and advancement of RIPK2 inhibitors.
dc.description.departmentPharmacological and Pharmaceutical Sciences, Department of
dc.format.digitalOriginborn digital
dc.format.mimetypeapplication/pdf
dc.identifier.urihttps://hdl.handle.net/10657/4016
dc.language.isoeng
dc.rightsThe author of this work is the copyright owner. UH Libraries and the Texas Digital Library have their permission to store and provide access to this work. Further transmission, reproduction, or presentation of this work is prohibited except with permission of the author(s).
dc.subjectRIPK2
dc.subjectKinase inhibitors
dc.subjectDrug design
dc.subjectNOD2 signaling
dc.titlePyrido-pyrimidinone Derivatives as RIPK2 Kinase and NOD Signaling Inhibitors
dc.type.dcmiText
dc.type.genreThesis
local.embargo.lift2020-08-01
local.embargo.terms2020-08-01
thesis.degree.collegeCollege of Pharmacy
thesis.degree.departmentPharmacological and Pharmaceutical Sciences, Department of
thesis.degree.disciplinePharmacology
thesis.degree.grantorUniversity of Houston
thesis.degree.levelDoctoral
thesis.degree.nameDoctor of Philosophy

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
NIKHAR-DISSERTATION-2018.pdf
Size:
6.25 MB
Format:
Adobe Portable Document Format
Download

License bundle

Now showing 1 - 2 of 2
No Thumbnail Available
Name:
PROQUEST_LICENSE.txt
Size:
4.44 KB
Format:
Plain Text
Description:
Download
No Thumbnail Available
Name:
LICENSE.txt
Size:
1.82 KB
Format:
Plain Text
Description:
Download

Collections

Published ETD Collection